May
2ND ANNUAL CDx & PERSONALIZED MEDICINE SUMMIT
2ND ANNUAL CDx & PERSONALIZED MEDICINE SUMMIT
The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices within the companion diagnostics (CDx) industry. More importantly, partnership opportunities and commercializing CDx tests with pharmaceutical and biotech companies will be explored.
KEY TOPICS
WHY YOU SHOULD BE THERE ?
- Novel Diagnostic Technologies
- Strategic Partnerships for CDx – Challenges and Opportunities
- Partnering strategies to achieve successful commercialization of CDx
- Future key areas for the Development of Personalized Medicine
- Partnering to Deliver Personalized Medicine
- Finding the appropriate business models for CDx companies
- Development of new Business Models for the Healthcare Industry
- The role of complementary diagnostics in targeted therapy selection
- Regulatory Update on Companion Diagnostics
- Emerging investment trends and opportunities
- Regulatory and Commercial Considerations
2. Learn about the latest technologies and most pressing topics specific to your business.
3. Discuss about new opportunities for your products and services with key decision makers.
4. Get new tips, tactics and implement the latest innovations.
5. Get an overview on innovative emerging technologies and business partnership opportunities.
6. Interact and connect with leading companies and their representatives.
MEDIA PARTNERS
REQUEST FORM
Nov
Global Pre-Filled Syringes Summit
ABOUT
Sharonat International is pleased to invite you to the “Global Pre-Filled Syringes Summit” scheduled on November 27 – 28, 2018 in Berlin, Germany
In this summit, the most successful and promising developments in Pre-Filled Syringes will be explored. This summit is one of the most important opportunities, where you will explore the best practices in PFS. It is particularly important for the fields key opinion leaders, most exciting newcomers and others to come together to discuss and learn about the up-to-the-minute trends.
The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices and explore business partnership opportunities. This premier B2B summit is one of the few opportunities, where you will meet face to face with leading industry professionals and decision makers and discuss your business potential and opportunities. It will also enable the participants to learn about the most advanced techniques and tools through which they can assess their portfolios and development potential.
Therefore, it is an honor and privilege to invite you to participate in this summit. We look forward to welcoming you at the “Global Pre-Filled Syringes Summit” in Berlin upcoming November!
KEY TOPICS
-
Latest regulations and the implications for the PFS industry
-
Next generation design and materials for PFS
-
Combination product and auto injectors
-
How to ensure quality and safety of pre-filled syringes
-
New Applications & Challenges
-
Anti-counterfeit strategies
-
Specialty syringes
-
Post-Market Surveillance Requirements – How to Implement?
-
Current market developments, trends and needs for PFS
-
Incorporating human factor engineering into a patient-centric device
WHY YOU SHOULD BE HERE
-
Network with business development and licensing professionals as well as professionals in your sector
-
Implement the latest innovations
-
Learn about the latest technologies and most pressing topics specific to your business
-
Get an overview on innovative emerging technologies and promote business partnerships within the sector
-
Interact and connect with leading professionals
-
Discuss about new opportunities for your products and services with key decision makers
FEATURED SPEAKERS
Dr. Graham B. Jones
Dr. Nicolas Brandes
Dr. Simon Kervyn
Steven Lynum
Katsuyuki Takeuchi
Vanessa Vankerckhoven, PhD
E Li
Takashi Hanada
MEDIA PARTNERS
Schedule
REQUEST FORM
Apr
2018 BIOTECH PHARMA WEEK
ABOUT
FEATURED SPEAKERS
Mag. Dr. Helmuth Haslacher, BSc BA
Peadar Mac Gabhann
Dr. Balwir Matharoo-Ball
Dr. Julie Barnes
Dr. Rita T. Lawlor, PhD
Paul Lomax
Robert Hewitt, MB BS, PhD
Dr. Dejun Tang
Cecil Nick
Fiona M Greer BSc (Hons) MSc PhD
Dr. Jakob Lange, Ph.D.
Dr. Steinar Madsen
Uwe Gudat
Fredrik Sundberg
Grzegorz Orlik, MD
Christian Maasch
Chantal LE FLOCH
FEATURED COMPANIES
MEDIA PARTNERS
REQUEST FORM
Feb
INTERNATIONAL BIOSIMILARS SUMMIT
INTERNATIONAL BIOSIMILARS SUMMIT
Sharonat International is pleased to invite you to the “International Biosimilars Summit” scheduled on November 29 – 30, 2018 in Berlin, Germany.
The biosimilars industry landscape is rapidly evolving and creating significant revenue opportunities for companies that can successfully develop and market them. According to the GBI research global biosimilars market value could hit $55 billion by 2020 from its current value of $20 billion, which clearly shows the industries trending business opportunities. Thus, this summit is one of the most important opportunities, where you will explore your business potential in this trending industry. It is particularly important for the fields key opinion leaders, most exciting new-comers and others to come together to discuss and learn about the up-to-the-minute trends of biosimilars, commercial strategy, effective planning and strategies for biosimilars future development, etc. It will bring together experts from all levels of the value chain to analyze and tackle the latest and greatest opportunities in the biosimilars industry. The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices and explore business partnership opportunities.
KEY TOPICS
WHY YOU SHOULD BE HERE ?
. Emerging investment trends and opportunities
. Innovative business models and their impact on biosimilar development
. The European biosimilar landscape, what does the future hold
. Commercial strategy to increase market uptake
. Forecasting biosimilar product portfolios and effectively planning and aligning business strategies for future changes
. Facilitating the acceptance and increasing the uptake of biosimilars
. The Experience Exchange: Developing and Introducing Biosimilars to New Markets
. Pharmacovigilance issues related to biosimilars
. Biosimilars In Emerging Markets – Regulatory and Commercial Considerations
. Learn about the latest technologies and most pressing topics specific to your business.
. Get an overview on innovative emerging technologies and business partnership opportunities.
. Interact and connect with leading companies and their representatives.
. Discuss about new opportunities for your products and services with key decision makers.
. Get new tips, tactics and implement the latest innovations.
FEATURED SPEAKERS
Cecil Nick
Fiona M Greer BSc (Hons) MSc PhD
Dr. Jakob Lange, Ph.D.
Dr. Steinar Madsen
Uwe Gudat
Fredrik Sundberg
Grzegorz Orlik, MD
Christian Maasch
Chantal LE FLOCH
FEATURED COMPANIES
MEDIA PARTNERS
REQUEST FORM
Feb
GLOBAL CDx & PERSONALIZED MEDICINE SUMMIT
GLOBAL CDx & PERSONALIZED MEDICINE SUMMIT
Personalized medicine will change the way medicine is practiced. The new therapies will benefit both patients and physicians in many ways. Patients will experience fewer side effects and physicians will be armed with more precise tools and medicine. Companion diagnostic co-development has the potential to significantly alter the drug development process and commercialization of drug candidates by yielding safer drugs with enhanced therapeutic efficacy in a faster, more cost-effective manner. This premier B2B summit will bring together experts from all levels of the value chain to analyze and tackle the latest and greatest opportunities in the CDx.
The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices within the companion diagnostics (CDx) industry. More importantly, partnership opportunities and commercializing CDx tests with pharmaceutical and biotech companies will be explored.
KEY TOPICS
WHY YOU SHOULD BE THERE ?
- Novel Diagnostic Technologies
- Strategic Partnerships for CDx – Challenges and Opportunities
- Partnering strategies to achieve successful commercialization of CDx
- Implementation of a Personalized Medicine program
- Emerging approach to precision medicine strategy
- Partnering to Deliver Personalized Medicine
- Finding the appropriate business models for CDx companies
- The role of complementary diagnostics in targeted therapy selection
- The laboratory developed test (LDT) & In vitro diagnostic (IVD) Models
- Liquid biopsy methodologies for non-invasive diagnostic development
- Next generation sequencing protocols
- Regulatory Update on Companion Diagnostics
2. Learn about the latest technologies and most pressing topics specific to your business.
3. Discuss about new opportunities for your products and services with key decision makers.
4. Get new tips, tactics and implement the latest innovations.
5. Get an overview on innovative emerging technologies and business partnership opportunities.
6. Interact and connect with leading companies and their representatives.
FEATURED SPEAKERS
SPONSORS
FEATURED COMPANIES
MEDIA PARTNERS
REQUEST FORM
Feb
WORLD BIOBANKING SUMMIT
WORLD BIOBANKING SUMMIT
Sharonat International is pleased to invite you to the “World Biobanking Summit” scheduled on November 29 – 30, 2018 in Berlin, Germany.
The global biobanking market was USD 142 million in 2011 and it is forecasted that this market will reach USD 216.3 million in 2018 with the compound annual growth rate of 5.4 % from 2011 – 2018. Moreover, the biobanking market witnessed an increased trend of mergers and acquisitions among vendors. This summit will address the latest developments in biobanking from its discovery to commercialization. It is one of the most important opportunities, where you will explore your business potential in biobanking. The U.S and Europe have the largest market size in biobanks. However, the rapid growth in population in Asia Pacific countries will affect the market of the developed countries. This summit will bring together experts from all levels of the value chain to analyze and tackle the latest and greatest opportunities in biobanking. The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices and explore business partnership opportunities.
KEY TOPICS
WHY YOU SHOULD BE HERE ?
. Quality management system in biobanking
. Fetal stem cell Banking
. Automated biobanking
. Gaps in global cancer stem cell Biobanks
. Ethical Issues in Stem Cell banking
. Latest technological developments in biobanking
. Strategic Partnerships for Biobanking – Challenges and Opportunities
. Biobanking In Emerging Markets – Regulatory and Commercial Considerations
. Learn about the latest technologies and most pressing topics specific to your business.
. Get an overview on innovative emerging technologies in biobanking and business partnership opportunities
. Interact and connect with leading companies and their representatives.
. Discuss about new opportunities for your products and services with key decision makers.
. Get new tips, tactics and implement the latest innovations.
FEATURED SPEAKERS
Mag. Dr. Helmuth Haslacher, BSc BA
Peadar Mac Gabhann
Dr. Balwir Matharoo-Ball
Dr. Julie Barnes
Dr. Rita T. Lawlor, PhD
Paul Lomax
Robert Hewitt, MB BS, PhD
